Arthroplasty Today· 2026Q1
When a Major Orthopaedic Device Manufacturer Does Not Offer Replacement Components for Revision Surgeries
- 0citations
- Q1SCImago
- 2026year
Short summary
A significant percentage of patients requiring revision hip or knee arthroplasty face unavailability of compatible replacement components from their original implant manufacturer in the US.
AI-generated from the title and abstract; the full text is not read.
Key points
- Patients needing revision hip or knee arthroplasty may not find compatible replacement parts from their original implant manufacturer in the US.
- Implant failure, whether early or late, can leave patients and surgeons without guaranteed appropriate, compatible components.
- Available options include less suitable or riskier implant parts, complex revision surgery, or a lengthy compassionate use approval process for custom implants.
AI-generated from the title and abstract; the full text is not read.
Abstract
Put yourself in the place of your patient: undertaking hip or knee arthroplasty for diminution of pain and return of mobility, only to find out a decade later that your implant is corroding and the appropriate replacement part is not commercially available in the United States. For a percentage of patients, this isn’t hypothetical—it’s reality. When artificial joints fail, early or late, surgeons and their patients are sometimes left with no guarantee of appropriate, compatible components. In such cases, the options are less suitable or riskier implant parts, higher surgical complexity involving the removal of otherwise well-positioned and ingrown components, or a lengthy and expensive compassionate use approval process for custom implants (via the Expanded Access pathway).
The authors' abstract, as published at the source. Arthroplasty Today, 2026 · DOI ↗
The rest is in the Pofolia app
Takeaways and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openMedical Laboratory TechnologyHealth Professions